retatrutide clinical trials safety efficacy vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide Phase 3 Results: Trials,

These ill effects are often temporary and dose-dependent, but they can affect your everyday life and change how you eat

When it comes to weight loss, theres no shortage of products that promise quick results

Consideration GLP-1 (Semaglutide) GLP-1 + GIP (Tirzepatide) New to medical weight loss programs Want to target appetite regulation and digestion speed Need added support for insulin response & fat metabolism Have tried GLP-1 therapy before without desired results Prefer to start with one mechanism before adding a second Interested in dual-hormone approach for multiple pathways 2x weekly dosing and personalized guidance Which GLP weight loss program is right for you

Phase 2 Trial: The Numbers The pivotal retatrutide Phase 2 trial (NEJM, June 2023, Jastreboff et al., NCT04881760) is the most-cited single source for retatrutide research statistics through to the readout of the Phase 3 TRIUMPH programme